The angiotensin-converting enzyme gene family: genomics and pharmacology

By Turner A.J.   Hooper N.M.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 4, 2002-04 ,pp. : 177-183

Elsevier

Access to resources Recommend Favorite

Effect of Angiotensin-converting Enzyme Inhibitors on Phenylephrine Responsiveness in Patients with Valvular Heart Disease

By Kwak HJ   Kwak YL   Oh YJ   Shim YH   Kim SH   Hong YW  

The Journal of International Medical Research, Vol. 33, Iss. 2, 2005-03 ,pp. : 150-159

Field House Publishing

Access to resources Recommend Favorite

Cost of Heart Failure in Patients Receiving -Blockers and Angiotensin-Converting Enzyme Inhibitors

By Weintraub W.S.  

Clinical Drug Investigation, Vol. 24, Iss. 5, 2004-01 ,pp. : 255-264

Adis International

Access to resources Recommend Favorite

The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease

By Brugts J.   Maat M.   Boersma E.   Witteman J.   Duijn C.   Uitterlinden A.   Bertrand M.   Remme W.   Fox K.   Ferrari R.   Danser A.   Simoons M.  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 171-181

Springer Publishing Company

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibition Influences Serum Levels of Advanced Glycation End Products in Patients with Coronary Artery Disease: Results from a HOPE Substudy

By  

Heart Drug, Vol. 3, Iss. 2, 2003-08 ,pp. : 67-72

Karger

Access to resources Recommend Favorite